Neurotransmitters and second messenger systems in the carotid body.
Pérez-García
M T
MT
Depto. Bioquímica y Biología Molecular y Fisiologia, Facultad de Medicina, Universidad de Valladolid, Spain.
Gómez-Niño
A
A
Almaraz
L
L
González
C
C
D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology; D000818:Animals; D018723:Bethanechol; D001626:Bethanechol Compounds / Q000494:pharmacology; D002344:Carotid Body / Q000187:drug effects / Q000378:metabolism*; D002395:Catecholamines / Q000378:metabolism*; D000242:Cyclic AMP / Q000378:metabolism*; D015232:Dinoprostone / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology; D005260:Female; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D007700:Kinetics; D008297:Male; D018377:Neurotransmitter Agents / Q000378:metabolism*; D011817:Rabbits; D015290:Second Messenger Systems / Q000187:drug effects; D012701:Serotonin / Q000494:pharmacology; D013373:Substance P / Q000494:pharmacology; D014443:Tyrosine / Q000378:metabolism
D001626:Bethanechol Compounds; D002395:Catecholamines; D018377:Neurotransmitter Agents; D018723:Bethanechol; D012701:Serotonin; D013373:Substance P; D014443:Tyrosine; D000242:Cyclic AMP; D015232:Dinoprostone; D007545:Isoproterenol; D015056:1-Methyl-3-isobutylxanthine; D004298:Dopamine